Clinical Trial Update: AXIS 2: AX200 for the Treatment of Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial of AX200 for acute ischemic stroke has completed, indicating the trial has reached its completion status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• AX200

Snippet

Sponsor: Sygnis Bioscience GmbH & Co KG | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED